Compass Therapeutics, Inc. (CMPX), a clinical-stage, oncology-focused biopharmaceutical company, on Monday announced that it has appointed Arjun Prasad as Chief Commercial Officer and Cynthia Sirard as Chief Medical Officer, effective as of January 1, 2026.
Cyndi brings more than two decades of experience in oncology drug development and previously served as Chief Medical Officer at Leap Therapeutics.
Before joining the company, Prasad was Chief Commercial Officer at Servier Pharmaceuticals.
In the pre-market trading, Compass Therapeutics is 6.19% higher at $5.49 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.